- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Mo | Otovo Acquires Soly Customers and Assets as it Expands Across Europe | 216 | Otovo acquires 24,000 customers and other assets from Soly for an approximately €0.75 million cash consideration
Otovo, a leading home energy service provider in the U.S. and Europe, today announced... ► Artikel lesen | ||
| Mo | Analystenbericht der GBC AG zu Mexedia S.p.A. Società Benefit abgeschlossen und veröffentlicht | 205 | Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) ("Mexedia" oder "Unternehmen") gibt bekannt, dass der von der GBC AG einem der führenden unabhängigen Finanzresearch-Unternehmen... ► Artikel lesen | ||
| Mo | Quanterix Corporation: Quanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence | 203 | Simoa p-Tau 217 Assay Enables Largest Population-Based Assessment (11,000+ Samples) Revealing Striking Age-Related Increase and Broad Treatment Eligibility
Quanterix Corporation(NASDAQ: QTRX),... ► Artikel lesen | ||
| Mo | Lithium Royalty Corp. Agrees to Be Acquired by Altius Minerals Corporation | 218 | TORONTO--(BUSINESS WIRE)--Lithium Royalty Corp. (the "Company" or "LRC") (TSX: LIRC) today announced that it has entered into a definitive arrangement agreement (the "Arrangement Agreement") with Altius... ► Artikel lesen | ||
| Mo | XCharge and EnBW Begin Expanded Testing of Fast-Charging Infrastructure | 284 | Eleven XCharge units deployed across four locations as part of EnBW's strategic testing program
HAMBURG, Germany--(BUSINESS WIRE)--XCharge is cooperating in testing with EnBW on their fast-charging-network... ► Artikel lesen | ||
| Mo | Newron Pharmaceuticals S.p.A.: Newron to Host Investor and Partnering Meetings During the J.P. Morgan Healthcare Conference Week | 268 | Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral... ► Artikel lesen | ||
| Mo | Vertical Aerospace Doubles Flight Test Capacity With Final Prototype | 190 | Final prototype to expand flight test capacity and enable public demonstrations Initial all-electric testing ahead of hybrid-electric flights in 2026 Vertical progresses towards full... ► Artikel lesen | ||
| Mo | Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference | 151 | Novocure (NASDAQ: NVCR) announced today that management will participate in the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco on January 12-15, 2026. Frank Leonard, Chief... ► Artikel lesen | ||
| Mo | Kolibri Global Energy Inc. Provides Operations Update | 153 | Kolibri Global Energy Inc. (the "Company" or "Kolibri") (TSX: KEI, NASDAQ: KGEI) is pleased to provide an operations update on its latest wells in its Tishomingo field in Oklahoma.
FIELD UPDATE... ► Artikel lesen | ||
| Mo | Access Advance LLC: Hisense tritt dem HEVC Advance Patentpool bei | 170 | Access Advance LLC, weltweit führend im Bereich der Lizenzierung von Video-Codec-Patentpools, gab heute bekannt, dass Hisense Group Holdings Co., Ltd. dem HEVC Advance Patent Pool als Lizenznehmer... ► Artikel lesen | ||
| Mo | KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Announces Approval of EKTERLY (sebetralstat) in Japan, First and Only Oral On-demand Treatment for Hereditary Angioedema | 198 | KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing approval for EKTERLY (sebetralstat)... ► Artikel lesen | ||
| Mo | Havas Reports the Progress of Transactions Under Its Current Share Buyback Program | 250 | Regulatory News:
Havas N.V. (EURONEXT: HAVAS) hereby reports transaction details related to the €50 million buyback program as communicated on May 28, 2025.
From December 15, 2025, up to and... ► Artikel lesen | ||
| Mo | Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson's Disease | 183 | Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the... ► Artikel lesen | ||
| Mo | Zambon Biotech meldet erste Dosisverabreichung der klinischen Phase-3b-Studie ADIP zu IPX203 bei Parkinson | 211 | Zambon Biotech ein spezialisiertes Biotechnologie-Unternehmen der Zambon-Unternehmensgruppe, das den Aufbau eines wissenschaftlich fundierten und wirtschaftlich tragfähigen Portfolios innovativer... ► Artikel lesen | ||
| Mo | Axelspace Corporation: Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch | 152 | Axelspace Corporation ("Axelspace"), a leading microsatellite company committed to making "Space within Your Reach," is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global... ► Artikel lesen | ||
| Mo | Omdia: Global Cloud Infrastructure Spending Hits $102.6 Billion, up 25% in Q3 2025 | 218 | According to new research from Omdia, global spending on cloud infrastructure services reached $102.6 billion in Q3 2025, representing 25% year-on-year growth. Market momentum remained stable, marking... ► Artikel lesen | ||
| Mo | viagogo: The Most Iconic Moments From Lily Allen, Lewis Capaldi, Katy Perry and Drake Revealed in Year in Live Experiences Report | 268 | From Lily Allen creating the ultimate diss album, Lewis Capaldi beating Drake and Kendrick, to Katy Perry's space adventure impacting her ticket sales a new report unlocks fans favourite moments in... ► Artikel lesen | ||
| Mo | Merck KGaA: Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor | 278 | First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved objective response rate... ► Artikel lesen | ||
| Mo | Merck: Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor | 289 | First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved objective response rate... ► Artikel lesen | ||
| Mo | KKR Launches European Rail Leasing Platform with Green Mobility Partners | 266 | Strategic partnership to scale newly established locomotive and train leasing company into a leading European rail leasing platform
Green Mobility Partners ("GMP"), a Vienna-based electric locomotive... ► Artikel lesen | ||
| Mo | Incyte Japan Announces Approval of Zynyz (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer | 225 | Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based... ► Artikel lesen | ||
| Mo | Incyte Japan Announces Approval of Minjuvi (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma | 217 | Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi (tafasitamab) in combination with rituximab and lenalidomide for adult... ► Artikel lesen | ||
| Mo | GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published | 163 | Regulatory News:
Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) ("Mexedia" or the "Company") informs that the analyst coverage report prepared by GBC AG one of... ► Artikel lesen | ||
| Mo | Cloudfresh Wins 2025 EMEA GitLab Partner of the Year Award for Emerging Markets in Eastern Europe and Israel | 190 | Cloudfresh, a certified GitLab Select and Professional Services Partner and a global leader in delivering multi-vendor cloud solutions, announced today that it has received the 2025 EMEA GitLab Partner... ► Artikel lesen | ||
| Mo | Coty Appoints Markus Strobel Executive Chairman and Interim CEO | 479 | Regulatory News:
Coty Inc. (NYSE: COTY) (Paris: COTY) ("Coty" or "the Company") today announced that Markus Strobel will become Executive Chairman of the Board and Interim Chief Executive Officer... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .